Drug profile · INN
valproic acid
VALPROIC ACID
valproic acid (VALPROIC ACID) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — valproic acid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 8
- Data quality
- 0.84
Quick answer
valproic acid (VALPROIC ACID) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Succinate semialdehyde dehydrogenase inhibitor
Primary target: Succinate-semialdehyde dehydrogenase, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is valproic acid?
valproic acid (VALPROIC ACID) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for valproic acid?
VALPROIC ACID is a marketed brand name for valproic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valproic acid?
valproic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.